Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CMMB Chemomab Therapeutics Ltd

-0.026 (-5.0%)
Dec 05 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 149,287
Bid Price 0.48
Ask Price 0.5225
News -
Company Name Stock Ticker Symbol Market Type
Chemomab Therapeutics Ltd CMMB NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.026 -5.0% 0.494 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.505 0.46 0.51 0.494 0.52
Trades Volume VWAP Dollar Volume Avg Volume
482 149,287  0.4942634  73,787 -
Last Trade Time Type Quantity Stock Price Currency
17:32:43 89  0.4801 USD

Chemomab Therapeutics Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 0 -27.65M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Chemomab Therapeutics

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CMMB Message Board. Create One! See More Posts on CMMB Message Board See More Message Board Posts

CMMB Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company's lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Your Recent History

Delayed Upgrade Clock